Anticancer activities of diphenyl difluoroketone, a novel curcumin analog, on KB human oral cancer cells

10Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Effects of diphenyl difluoroketone (EF-24) and curcumin on cell growth and apoptosis induction in KB human oral cancer cells were examined. EF-24 and curcumin inhibited the growth of KB cells in a dose-dependent manner, and the potency of EF-24 was 30 times greater than that of curcumin. Treatment with EF-24 or curcumin resulted in nuclear condensation and fragmentation. EF-24 and curcumin promoted the proteolytic cleavage of procaspases-3, -7, and -9. Activities of caspases-3 and -7 were detected in living KB cells treated with EF-24 or curcumin. These results suggest that EF-24 and curcumin inhibit cell proliferation and induce apoptosis in KB human oral cancer cells, and have potential properties for development of anti oral cancer drug. © 2012 The Korean Society for Applied Biological Chemistry.

Cite

CITATION STYLE

APA

Jeon, H. S., Jo, M. H., Kim, H. J., Lee, M. H., Yu, S. K., Kim, C. S., … Kim, D. K. (2012). Anticancer activities of diphenyl difluoroketone, a novel curcumin analog, on KB human oral cancer cells. Journal of the Korean Society for Applied Biological Chemistry, 55(4), 451–456. https://doi.org/10.1007/s13765-012-1168-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free